TMPRSS2 and COVID-19: Another TMPRSS2 inhibitor with broad distribution capability, bromhexine, has reduced the mortality of COVID-19 patients in clinical trials and is a potential therapeutic option as an inexpensive and safe over-the-counter drug [104].